ClinicalTrials.gg
Active, not recruitingNCT06299189MinADHDUpdated Nov 19, 2026

A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care

An interventional study of MinADHD in ADHD, ADHD - Combined Type and ADHD Predominantly Inattentive Type, sponsored by Haukeland University Hospital. Active, not recruiting at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Haukeland University Hospital · Not applicable, Interventional, and Treatment

How we know

Updated Nov 19, 2026Now Active, not recruitingGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 30 studies in Attention Deficit Disorder with Hyperactivity with a site in Norway — 4 open to participants now, 7 under way, none of them phase 3. Attention Deficit Disorder with Hyperactivity · Norway.

Planned enrollment
7th of 25
200 · median 100
Started
2024
with 1 other
No phase
17 of 30
3 open now
Registered
27th of 30
by date
Lead sponsor
3 of 30
Haukeland University Hospital

Among the 30 studies in Attention Deficit Disorder with Hyperactivity with a site in Norway, this one is the 7th largest by planned enrollment of the 25 interventional ones that give a count, is one of 2 that started in 2024, is one of 17 with no phase, and was the 27th registered.

Attention Deficit Disorder with Hyperactivity

1,821 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 297 are open to participants now.

Browse Attention Deficit Disorder with Hyperactivity studies →

Open to participants now

4 of the 30 studies in Attention Deficit Disorder with Hyperactivity with a site in Norway are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Norway have not opened yet or have stopped. Only those recruiting at a site in Norway →

Who these studies take

Of the 200 Attention Deficit Disorder with Hyperactivity studies recruiting now, 26 (13%) set no upper age limit and 169 (85%) stop at 75 or younger; 141 take children under 18; 55 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 30 studies in Attention Deficit Disorder with Hyperactivity with a site in Norway, or all of them as a file.
02

Study summary

The primary objective of this study is to explore and evaluate the use and utility of a guided Internet-delivered psychological treatment for adults with ADHD with a combined focus on:

i) Evaluating the impact of potential predictors to treatment adherence, treatment response, treatment use and utilty. ii) Evaluating the feasibility, clinical benefits and implementation process of the treatment in routine outpatient care. iii) Evaluate the cost-effectiveness of the treatment program.

Read the detailed description

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by symptoms of inattention and/or hyperactivity/impulsivity that are persistent across time and situations. ADHD in adulthood, with estimated prevalence of 2-3%, is associated with challenges that may have severe consequences on daily life functioning. Treatments delivered over the Internet on smartphones or personal computers may help to increase the availability of effective psychological interventions for a larger group of adults with ADHD. The overall aim of this study is to investigate 1) predictors of effect; 2) implementation outcomes; and the 3) cost-benefit of a therapist guided Internet-delivered treatment for adults with an ADHD diagnosis. The study is an open longitudinal cohort trial in routine care. A total of 200 participants with an ADHD diagnosis will be included in the trial, and 15 participants will be interviewed about their experiences with guided Internet-delivered treatment. The outcomes are change in primary and secondary symptoms and quality of life, cost-benefit and implementation outcomes of guided internet-delivered treatment for adults with ADHD. The investigators will use quantitative statistical procedures and qualitative methods to analyze the data. The results from the study will contribute to the growing research on Internet-delivered treatments. The expected results may have a major impact on treatment provision and the further development of treatment options for adults with ADHD. Moreover, investigating ways to increase adoption, adherence and fidelity in Internet-delivered treatment could be of great value when implementing such treatment into routine care.

03

Conditions studied

  • ADHD
  • ADHD - Combined Type
  • ADHD Predominantly Inattentive Type
  • ADHD, Predominantly Hyperactive - Impulsive
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion criteria: \|

  • Age ≥18
  • A self-reported diagnosis of ADHD
  • Access to and ability to use a computer, smartphone and the Internet.
  • Speaks, writes and reads Norwegian

Exclusion criteria:

  • In need of other psychological treatment for mental health illness such as borderline or personality disorder, bipolar disorder, substance abuse or psychosis.
  • Ongoing psychological treatment for ADHD or other psychiatric illnesses.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    A self-guided internet delivered intervention

    MinADHD: 7 self-help modules Interventions: Behavioural

    Behavioral: MinADHD

Interventions

  • BehavioralMinADHD

    Guided self-help, 7 modules Interventions

06

What researchers measure

Primary outcomes

  1. The Adult ADHD Self-Rating Scale

    Measure of ADHD symptom severity

    Time frame: From enrollment to the end of 6-months follow-up

  2. Adult ADHD Quality of Life Measure

    Measure of impact of ADHD on quality of life

    Time frame: From enrollment til the end of 6-month follow-up.

Secondary outcomes

  1. The Patient Health Questionnaire

    Measure of depression

    Time frame: From enrollment til the end of 6-month follow-up.

  2. Generalized Anxiety Disorder-7

    Measure of anxiety

    Time frame: From enrollment til the end of 6-month follow-up.

  3. Personality Disorder Severity ICD-11

    Measure of personality functioning

    Time frame: From enrollment til the end of 6-month follow-up.

  4. EuroQoL 5D-5L

    Measure of health-related quality of life

    Time frame: From enrollment to end of 6-month follow-up.

07

Study locations

1 site
  • Bjørgvin DPS
    Bergen, Norway
08

References and documents

Individual participant data

Plan to share: No — The IPD collected for the current trial is considered sensitive patient information.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Sep 2027, 44 months after the start.

Of 480 non-industry interventional studies with no phase under Attention Deficit Disorder with Hyperactivity, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 43. This study's planned 44 months is above that.

Counting every sponsor, half of 511 studies reached it within 23 months; a quarter within 11 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 28, 2024
First posted
Mar 7, 2024
StartActual
Jan 1, 2024
Primary completionEst.
Sep 2027
CompletionEst.
Sep 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting
changed Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Recruiting→Active, not recruiting
    + 4 other changes: verification date, oversight details, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06299189
Responsible party
Sponsor
First posted
Mar 7, 2024
Start date
Jan 1, 2024
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Nov 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion